Explore News
-
Next-Gen GLP-1 Drug Survodutide Shows 16% More Weight Loss Than Zepbound
A phase 3 trial reveals survodutide, a dual GLP-1 and glucagon receptor agonist, led to…
-
Why GLP-1 Medications Like Ozempic Have Unreported Side Effects
New research uncovers overlooked side effects of GLP-1 medications
-
New Study Reveals GLP-1 Drugs May Treat Anxiety
Research suggests dual benefits for metabolic and mental health
